Oncolytics Biotech
ONCY
#9623
Rank
$0.10 B
Marketcap
$0.85
Share price
2.50%
Change (1 day)
-28.71%
Change (1 year)

Oncolytics Biotech (ONCY) - Cash on Hand

Cash on Hand as of March 2026 : $5.49 Million USD

According to Oncolytics Biotech 's latest financial reports the company has $5.49 Million USD in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Oncolytics Biotech - Cash on Hand chart (from 2000 to 2026)

Cash on Hand by year

Year Cash on Hand Change
2025-12-31$5.2 M-53.05%
2024-12-31$11.07 M-57.9%
2023-12-31$26.31 M11.14%
2022-12-31$23.67 M-26.83%
2021-12-31$32.36 M32.18%
2020-12-31$24.48 M126.05%
2019-12-31$10.83 M7.68%
2018-12-31$10.05 M6.86%
2017-12-31$9.41 M-10.42%
2016-12-31$10.5 M-44.08%
2015-12-31$18.79 M34.79%
2014-12-31$13.94 M-45.47%
2013-12-31$25.56 M19.45%
2012-12-31$21.4 M-37.3%
2011-12-31$34.13 M-20.42%
2010-12-31$42.89 M31.62%
2009-12-31$32.59 M198.77%
2008-12-31$10.9 M-57.15%
2007-12-31$25.46 M7.47%
2006-12-31$23.69 M-31.91%
2005-12-31$34.79 M23.3%
2004-12-31$28.21 M76.31%
2003-12-31$16 M202.84%
2002-12-31$5.28 M-43.81%
2001-12-31$9.4 M-19.97%
2000-12-31$11.74 M274.09%
1999-12-31$3.14 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Eli Lilly
LLY
$5.28 B 96,058.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$10.48 B 190,797.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Mirati Therapeutics
MRTX
$0.97 B 17,675.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Aeterna Zentaris
AEZS
$27.8 M 406.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
$3.74 B 68,004.86%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
AVEO Oncology
AVEO
$77.39 M 1,309.03%๐Ÿ‡บ๐Ÿ‡ธ USA